Louisiana Tech University has announced its 2025 Spring Quarter president’s and dean’s honor lists.

American three-time Olympic swimming star Lilly King has announced the upcoming Toyota National Championships in Indianapolis will be her final meet on U.S. soil.

Eli Lilly and Company (NYSE: LLY) and SiteOne Therapeutics, Inc. ("SiteOne"), a private biotechnology company developing small molecule inhibitors of sodium channels to treat pain and other ...

The creator of Sirens explained the abundance of Lilly Pulitzer dresses and what those lockets really mean.

Pharmaceutical Executive: Can you provide a breakdown on the data presented at DDW 2025? Mark Genovese, MD: At DDW this year, Lilly highlighted data from multiple studies that show Omvoh® (mirikizumab ...

Walmart shared that it is expanding its central fill network to provide coverage to nearly 90% of all Walmart pharmacies by the end of 2026, while meeting the growing demand for more convenient ...

Frederick, MD 21703 Phone: 301-662-1177 Email: webmaster@fredericknewspost.com. Trust the Hometown Guru. Local favorites, as voted by locals. Find Frederick's Best. Manage your account.

Eli Lilly and Company’s LLY shares have lost 17% so far in May. Lilly announced mixed earnings results on May 1. It missed first-quarter estimates for earnings but beat the same for sales. Sales ...

Castillo’s Knights improved to 7-6 on the season and remain undefeated in the Class 5A Granite Peaks League at 5-0. Meanwhile, Frederick saw its recent momentum come to a halt.

Lilly has a strong portfolio of GLP-1 drugs that have helped propel its growth. Last quarter alone, its two leading GLP-1 drugs, Mounjaro and Zepbound, generated a combined $5.4 billion in revenue.

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight loss. Latest U.S.

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its latest clinical testing, the Indianapolis-based drugmaker announced Thursday.